Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a nanosystem that uses "quantum dots" to improve the imaging of human…
The appointment of Churcher as VP of drug discovery furthers the secretive AI-enabled startup’s track record of poaching execs from Big Pharma.
RBM is, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site- and patient-centric environment.
IBM and JDRF will use machine learning to identify risk factors that cause the onset of Type 1 diabetes in children.
Tandem started a pivotal trial of a system that automatically stops insulin delivery when a patient’s blood glucose levels are predicted to fall.
Medtronic is recruiting patients for a clinical trial that will investigate one-month DAPT in patients treated with its latest drug-eluting stent.
The partnerships give Alexion access to modeling and simulation software used by Celgene and a partner to support its push into genomics.
Abbott has enrolled the first patient in a clinical study to investigate its clip-based system as a treatment for leaky tricuspid valves.
23andMe, the Milken Institute and Lundbeck are recruiting 25,000 people for a genetic study on major depressive and bipolar disorders.
The decision to can the program follows a succession of setbacks for Abbott’s rival stent that have dented the sector’s hopes of generating big sales.
Roche has joined partners Senseonics and TypeZero to develop a closed-loop system for insulin delivery.